Project Grant R01EY033905

Award Date 8/1/23
Completion Date 3/31/28
Dollars Obligated $2M
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Pasadena, CA 91103, USA
Similar Awards
This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), is focused on investigating the molecular and physiological mechanisms of inner retinal remodeling in the context of retinal degeneration. The primary awardee, the University of Rochester, will receive $437,310 over the 5-year project period from March 1, 2025 to February 28, 2030. The research aims to elucidate the genetic, morphological, and physiological changes...
This Project Grant award from the National Eye Institute (NEI), part of the U.S. Department of Health and Human Services, under the Vision Research (CFDA 93.867) program, provides $500,500 to support research on the role of retinal ganglion cells in shaping the identity and function of neurons in the superior colliculus visual processing region. The key objectives are to: 1) determine how retinal input influences the morphology and transcriptional profiles of genetically-defined neuron...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), will support research to investigate the cellular and synaptic mechanisms underlying changes in retinal ganglion cell (RGC) activity following optic nerve injury in mouse models of glaucoma. The $460,625 award, with a project period from September 30, 2024 to September 29, 2026, will enable researchers at Yale University to: (1) determine the underlying mechanisms responsible for...
This National Eye Institute (NEI) Vision Research (CFDA 93.867) Project Grant award of $387,428 supports research to investigate fundamental mechanisms driving optic nerve sensitivity to elevated intraocular pressure (IOP) in glaucoma. The 5-year project, led by the Research Foundation for the State University of New York (Upstate Medical Center), aims to determine how transient biomechanical strains on optic nerve head astrocytes may predispose them to glaucomatous dysfunction. The research...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), provides $1,600,857 in funding to Baylor College of Medicine to investigate the role of serotonin and serotonin receptors in normal and glaucomatous retinal ganglion cell function. The key objectives are to: 1) Determine the cell-type specific function of the serotonin receptor HTR1B in the inner retina; 2) Elucidate the intracellular mechanisms of action of HTR1B in retinal...
This federal Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), is focused on leveraging single cell stimulation to map human retinal ganglion cell receptive fields. The primary objective is to directly connect light stimulation of individual retinal photoreceptors to the activity of retinal ganglion cells and the resulting conscious visual perception. This $227,265 award to the University of California, Berkeley will allow the researchers...
This federal Project Grant award from the National Eye Institute (NEI), under the Vision Research grant program (CFDA 93.867), provides $116,888 to The Regents of the University of California, San Francisco (UCSF) to study the interaction of perivascular retinal ganglion cells (RGCs) with blood vessels through mechanosensitive channels. The research aims to understand how these perivascular RGCs, which express the mechanosensitive channel Piezo2, respond to both light stimuli and mechanical...
The National Eye Institute (NEI) awarded a $487,862 Project Grant (CFDA 93.867 - Vision Research) to the University of Washington to investigate how the retina encodes visual information in dynamic natural environments. The overarching goal is to understand how rapid and large fluctuations in light intensity, which frequently occur as an animal moves through its environment, impact retinal function and visual signaling. The research aims to: 1) Determine the role of adaptation in...
This Project Grant award, R21EY036552, was provided by the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867). The $191,095 award will support research at the University of North Texas Health Science Center at Fort Worth to investigate how metabolic changes in optic nerve head cells, particularly astrocytes and lamina cribrosa cells, contribute to the development of fibrosis in glaucoma. The key goals are to establish the role of the YAP/TAZ signaling...
The National Eye Institute (NEI) awarded a $491,466 Project Grant (CFDA 93.867 - Vision Research) to the University of California, San Francisco (UCSF) to develop a novel, non-invasive, and sensitive measure of retinal dysfunction. The project aims to expand upon the researchers' preliminary data demonstrating the ability to detect graded cone loss in mice using a visually-evoked compensatory behavior known as the optokinetic reflex (OKR). The goal is to translate this methodology to the...

RETINAL GANGLION CELL SIGNALING REGULATED BY INTRINSIC REACTIVE OXYGEN SPECIES - PROJECT ABSTRACT THIS PROPOSAL TO INVESTIGATE THE IMPACT OF THE BIOENERGETICALLY-REGULATED, METABOLIC ENVIRONMENT ON THE SENSITIVITY AND SIGNALING OF RETINAL GANGLION CELLS BLENDS TWO CONVERGING LINES OF INQUIRY. THE FIRST ARISES FROM EVIDENCE THAT NEURONAL METABOLIC STRESS IS ACCOMMODATED WITHIN DIVERSE AND COMPLEX SOLUTIONS. THE SECOND STEMS FROM OUR EXTENSIVE KNOWLEDGE OF GANGLION CELL SIGNALING FUNCTIONS, SOME OF WHICH WE NOW INTERPRET AS ADAPTIONS TO THE CONSEQUENCES OF FLUCTUATING ENERGY REQUIREMENTS. THE FOCUS OF THIS PROPOSAL IS ON IDENTIFIED GANGLION CELL RESPONSES TO LIGHT AND HOW CHANGES TO SPECIFIC RESPONSE FEATURES ARE MODULATED BY INTRINSIC METABOLIC ACTIVITY. THERE IS A GAP IN OUR UNDERSTANDING OF HOW THE DIFFERENT RESPONSE-FORMING FUNCTIONS OF CELLULAR EXCITABILITY MAY BE CHANGED DURING METABOLIC STRESS AS WELL AS THE DEGREE OF THE CONSEQUENCES OF THESE CHANGES TO GANGLION CELL SENSITIVITY AND VISUAL FUNCTION OVERALL, ESPECIALLY DURING THE PATHOLOGICAL CONDITIONS THAT LEAD TO GANGLION CELL LOSS. OUR INVESTIGATIONS WILL TEST HYPOTHESES THAT INTERSECT AT THE BIOENERGETIC STATE OF THE RETINA AND ITS EFFECTS ON THE SIGNALING OF GANGLION CELLS. IN SPECIFIC AIM 1, WE WILL DEFINE HOW THE NORMAL ENVIRONMENTAL CONDITIONS OF THE OUTER RETINA CONTRIBUTE TO THE RESPONSE FEATURES OF GANGLION CELLS. WE WILL TEST THE HYPOTHESIS THAT INTRINSIC METABOLIC ACTIVITY HAS A KEY INFLUENCE ON GANGLION CELL LIGHT RESPONSES BY COMPARING CONTROLLED OXIDANT MODULATION OF THE CELLS' RESPONSE WAVEFORMS. IN SPECIFIC AIM 2, WE WILL CHARACTERIZE THE OXIDANT SENSITIVITY OF THE CELLS' EXCITABILITY MECHANISMS RESPONSIBLE FOR GANGLION CELL ACTION POTENTIAL GENERATION. WE WILL TEST THE HYPOTHESIS THAT THE METABOLIC ACTIVITY OF EACH GANGLION CELL AND ITS NEIGHBORS INFLUENCES THESE SIGNALING MECHANISMS VIA OXIDANT PRODUCTION. IN SPECIFIC AIM 3, WE WILL EXAMINE THE NET INFLUENCE OF METABOLIC MODULATION CAUSED BY LIGHT INTENSITY CHANGES (CONTRAST ADAPTATION) ON GANGLION CELL OUTPUT. WE WILL TEST HOW THE ACTIONS OF OXIDANTS ON SPECIFIC FEATURES OF THE GANGLION CELL RESPONSES REFLECT THE CELL'S METABOLIC STATE, AND HOW THEY ADJUST RETINAL OUTPUT IN NORMAL AND PATHOPHYSIOLOGICAL CONDITIONS. THESE PROPOSED STUDIES WILL FURTHER OUR UNDERSTANDING OF THE CELLULAR MECHANISMS THAT UNDERLIE GANGLION CELL RESPONSES AND RETINAL OUTPUT. OUR OBJECTIVES ARE CONSISTENT WITH THE HEALTH-RELATED GOALS OF THE NATIONAL EYE INSTITUTE FOR UNDERSTANDING NEUROPROTECTIVE MECHANISMS IN RETINAL NEURONS TO PREVENT NEURODEGENERATION, INCLUDING THAT INDUCED BY EXCESSIVE LEVELS OF METABOLIC BYPRODUCTS, AS WELL AS UNDERSTANDING THE ORIGIN OF DYSFUNCTIONAL RETINAL SIGNALS THAT ARE DETECTED WITH CLINICAL TOOLS ESSENTIAL FOR DIAGNOSING AND ASSESSING THE PROGRESSION OF RETINAL DISEASE.

Posted 7/21/23, 12:00 AM